Back to search

National and Kapodistrian University of Athens

Κλινική αξιολόγηση της καλλικρεΐνης 13 (KLK13) στον καρκίνο της ουροδόχου κύστης

Abstract

dc:description

Despite research advantages on the molecular and subcellular background, bladder cancer (BlCa) remains a clinically neglected malignancy. This is strongly reflected by the generic approach of disease diagnosis and management. Additionally, patients’ prognosis became a rather demanding task due to the great disease heterogeneity. Here, we aimed to evaluate, for the first time, the clinical value of KLK13 in BlCa. 279 bladder specimens (137 tumors, 107 adjacent normal and 35 healthy samples) were included. Total RNA was extracted, reversed transcribed, and KLK13 expression was assessed by quantitative real-time PCR. KLK13 expression is significantly increased in bladder tumors compared to normal epithelium. However, reduced KLK13 expression is correlated with disease aggressiveness, including higher tumor stage and grade, and high-risk TaT1 tumors according to the EORTC stratification. Moreover, Kaplan-Meier and Cox regression analysis highlighted the prognostic value of the reduced KLK13 expression for the prediction of TaT1 patients’ recurrence and shorter disease-free survival following TURBT. This first clinical study of KLK13 in BlCa reveals its deregulated expression in bladder tumors and highlights KLK13 as a promising marker for improving patients’ prognosis following treatment.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tokas, Theodoros
  • Τόκας, Θεόδωρος

Subjects

dc:subject × 16

Rights

dc:rights
Statement dc:rights
  • BY_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40866

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tokas, Theodoros; Τόκας, Θεόδωρος. Κλινική αξιολόγηση της καλλικρεΐνης 13 (KLK13) στον καρκίνο της ουροδόχου κύστης. National and Kapodistrian University of Athens, 2017. http://hdl.handle.net/10442/hedi/40866